Skip to content
Opus Dei Tech

Healthcare Investors

Independent assessment of technology and execution risk.

Diligence on a healthcare technology or AI company depends on questions that generalist technical review does not ask.

Challenges

What this audience is dealing with.

  • AI claims

    Distinguishing model capability from deployable healthcare value.

  • Product maturity

    Whether the product is repeatable or a set of custom implementations.

  • Workflow fit

    Whether the product has a durable place in the buyer's operations.

  • Execution risk

    Whether the team can implement, integrate and scale.

Where we help

The work we do here.

  • AI capability and readiness assessment
  • Product and technology maturity review
  • Workflow and buyer validation
  • Integration and implementation risk assessment
  • Independent Healthcare AI Audit

Potential outcomes

What the work is designed to improve.

  • A clear view of what is proven and what is asserted
  • Named execution and integration risks
  • Grounded questions for management
  • A prioritized post-investment action list

Healthcare adoption cycles punish products that ignore workflow and integration. Those factors predict outcomes better than model benchmarks.

Outcomes depend on organizational context, implementation and evidence; they are not guarantees.

Start here

Before You Invest in Healthcare AI, Know Whether It’s Ready.

Get an independent readiness assessment before you invest, deploy or scale.